Patents expiring in 2035

US 9206257

Human monoclonal antibodies specific for glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9206428

RNAi-mediated inhibition of histamine receptor H1-related conditions

Arrowhead Research Corporation · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9206421

Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9206423

Methods of modulating compliance of the trabecular meshwork

The Regents of the University of California · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9207243

Use of GLUT4 inhibitors and DNA damaging agents for treating multiple myeloma

Northwestern University · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9206183

Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors

Almirall, S.A. · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9205131

Use of IL-17D for the treatment and prevention of cancers

The Regents of the University of California · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9205088

Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use

PTC THERAPEUTICS, INC. · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9205048

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2952200

Allergen zur vorbeugenden Behandlung von Allergien

ALK ABELLÓ AS [DK] · Granted Wed Dec 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2015187736

FORMULATIONS PLACEBO ET UTILISATIONS DE CELLES-CI

ALLERGEN RES CORP [US] · Granted Thu Dec 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211302

Modulation of LRCH4 activity and therapeutic application thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211315

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

HALOZYME, INC. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212147

Dihydroxy aromatic heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212129

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

VANDA PHARMACEUTICALS INC. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211419

Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy

The Board of Regents of the University of Texas System · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212168

Hepatitis C virus inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212364

Compositions and methods for inhibiting expression of mutant EGFR gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212218

Vmp-like sequences of pathogenic Borrelia

The Board of Regents of the University of Texas System · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212212

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211277

Dietary supplement composition

YOUNG LIVING ESSENTIAL OILS, LC · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211289

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211328

Modulation of NKG2D for prolonging survival of a hematopoietic graft

The Regents of the University of California · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211323

Compositions and methods for administration of vaccines against dengue virus

Takeda Vaccines, Inc. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212149

Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212191

6-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitor

GILEAD CONNECTICUT, INC. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9212273

Elastomer formulations

MOLECULAR REBAR DESIGN, LLC · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9210925

Multipotent postnatal stem cells from human periodontal ligament and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211244

Method for anti-skin aging using caffeamide derivative

China Medical University · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211275

Ketone bodies and ketone body esters as blood lipid lowering agents

The United States of America, as represented by the Secretary of the Department of Health and Human Services (DHSS) · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2951771

COMPOSITIONS ET METHODES PERMETTANT DE PREVENIR LES INFECTIONS

BIOCODEX [FR] · Granted Thu Dec 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2015359783

PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF

BIAL PORTELA & Cª S A [PT] · Granted Thu Dec 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216983

Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

The Board of Regents of the University of Texas System · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9217040

Therapeutic antibodies against ROR-1 protein and methods for use of same

The Regents of the University of California · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9217148

Exon skipping compositions for treating muscular dystrophy

Sarepta Therapeutics, Inc. · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216969

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216993

Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216213

Adjuvanted rabies vaccine with improved viscosity profile

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216240

Differential loading of drug-eluting medical devices

Covidien LP · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216220

Compositions and methods for thermo-sensitive nanoparticles and magnetic nanoparticles

The Board of Regents of the University of Texas System · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216198

Compositions and medical devices for controlled release of nitric oxide and methods of production thereof

The Board of Regents of the University of Texas System · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9217024

ADDL receptor polypeptides, polynucleotides and host cells for recombinant production

Acumen Pharmaceuticals, Inc. · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9217007

Platinum anticancer agents

The Regents of the University of California · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216970

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9217026

Method of inactivating a glucocorticoid receptor gene in an isolated cell

Sangamo Biosciences, Inc. · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9217010

N-substituted indenoisoquinolines and syntheses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216214

Replication-competent adenoviral vectors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216971

Quaternary ammonium compounds useful as muscarinic receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)